Vemurafenib and Dabrafenib Downregulates RIPK4 Level
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15030918
Abstract: Simple Summary RIPK4 kinase has oncogenic functions in melanoma and shows high similarity to BRAF protein, making this kinase sensitive to the BRAF inhibitors vemurafenib and dabrafenib. BRAFi downregulates RIPK4 in both BRAF-mutated and wild-type… read more here.
Keywords: braf; kinase; ripk4; downregulates ripk4 ... See more keywords